Preeclampsia Definition
BP ≥ 140/90 mmHg after 20 weeks gestation plus proteinuria (≥ 300 mg/24h or UPCR ≥ 0.3) or severe end-organ dysfunction.
Severe Preeclampsia
BP ≥ 160/110 mmHg, platelets < 100,000/μL, AST/ALT > 2× ULN, Cr > 1.1 mg/dL, pulmonary edema, or cerebral/visual symptoms.
Eclampsia & Magnesium
First-line seizure prophylaxis and treatment: IV Magnesium Sulfate (4–6 g load, 1–2 g/hr). Antidote: IV Calcium Gluconate.
Placenta Previa vs. Abruption
Previa: painless bright red bleeding (NEVER perform digital vaginal exam!). Abruption: painful dark bleeding, rigid hypertonic uterus.
VEAL CHOP Mnemonic
Variable = Cord compression; Early = Head compression; Accelerations = OK; Late = Placental insufficiency.
Shoulder Dystocia
Turtle sign → First-line: McRoberts maneuver + Suprapubic pressure. NEVER apply fundal pressure (causes uterine rupture/Erb palsy).
Postpartum Hemorrhage (4 Ts)
Tone (Uterine Atony, 70%), Trauma (lacerations/inversion, 20%), Tissue (retained placenta, 10%), Thrombin (DIC, 1%).
Sacral Mechanics in Labor
Sacral base moves anteriorly (nutation / flexion) as fetal head exits the pelvic outlet; Sympathetics T10–L2, Parasympathetics S2–S4.
Hypertensive Disorders of Pregnancy Classification
Categorization based on gestational timing and end-organ damage:
| Disorder | Onset Timing | Blood Pressure Criteria | Defining End-Organ Features |
|---|---|---|---|
| Chronic Hypertension | Prior to pregnancy or < 20 weeks gestation | BP ≥ 140/90 mmHg | Persists > 12 weeks postpartum; no new proteinuria |
| Gestational Hypertension | Onset ≥ 20 weeks gestation | BP ≥ 140/90 mmHg | No proteinuria; no severe features; resolves postpartum |
| Preeclampsia | Onset ≥ 20 weeks gestation | BP ≥ 140/90 mmHg | Proteinuria (UPCR ≥ 0.3 or 300 mg/24h) or any severe feature |
| Preeclampsia with Severe Features | ≥ 20 weeks gestation | BP ≥ 160/110 mmHg on 2 occasions | Thrombocytopenia (< 100k), AST/ALT > 2x ULN, Cr > 1.1, pulmonary edema, persistent vision changes/headache |
| HELLP Syndrome | Late 2nd / 3rd trimester or postpartum | Hypertension present in 85% | Hemolysis (schistocytes, LDH > 600), Elevated Liver enzymes, Low Platelets (< 100k) |
| Eclampsia | ≥ 20 weeks or early postpartum | Hypertension | New-onset grand mal tonic-clonic seizures in preeclamptic patient |
Pathogenesis of Spiral Artery Remodeling Failure & Severe Features of Preeclampsia
Normal placentation requires fetal extravillous cytotrophoblasts to invade the maternal uterine decidua and remodel high-resistance muscular spiral arteries into low-resistance, high-capacitance vessels. In Preeclampsia (new-onset hypertension ≥140/90 mmHg after 20 weeks gestation plus proteinuria ≥300 mg/24h or urine protein/creatinine ratio ≥0.3, or end-organ dysfunction), defective cytotrophoblast invasion causes placental hypoxia and release of anti-angiogenic soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin, which bind maternal VEGF and PlGF to induce widespread maternal systemic endothelial dysfunction, vasospasm, and capillary leak. Preeclampsia with Severe Features is diagnosed when BP reaches ≥160/110 mmHg OR any end-organ marker is present: thrombocytopenia (<100,000/μL), transaminases ≥2× ULN or persistent RUQ/epigastric pain (Glisson capsule stretch), serum creatinine >1.1 mg/dL (or doubling), pulmonary edema, or new-onset cerebral/visual disturbances (scotomata, photopsia, severe headache).
Delivery Timing Cutoffs (37w vs. 34w), Safe Antihypertensives & Magnesium Sulfate Toxicity
Definitive cure of preeclampsia and HELLP syndrome (Hemolysis with schistocytes, Elevated Liver enzymes, Low Platelets) is delivery of the placenta: for gestational hypertension or preeclampsia WITHOUT severe features, expectant management is continued until delivery at 37 0/7 weeks gestation; for preeclampsia WITH severe features, stabilize the mother and deliver at 34 0/7 weeks gestation (or immediately regardless of gestational age if eclampsia, HELLP syndrome, pulmonary edema, DIC, placental abruption, refractory severe hypertension, or non-reassuring fetal status is present). Acute severe hypertension (≥160/110 mmHg) is treated within 30–60 minutes to prevent maternal hemorrhagic stroke using IV Labetalol, IV Hydralazine, or Immediate-Release Oral Nifedipine (chronic safe outpatient options: Labetalol, Nifedipine, Methyldopa; ACEi, ARBs, direct renin inhibitors, and nitroprusside are strictly teratogenic/contraindicated). Intrapartum and 24-hour postpartum seizure prophylaxis requires IV Magnesium Sulfate; because magnesium is excreted 100% renally, monitor sequentially for toxicity: loss of patellar deep tendon reflexes (first sign at 7–10 mEq/L) → respiratory depression (10–13 mEq/L) → cardiac arrest (>15 mEq/L), treated by stopping the infusion and administering IV Calcium Gluconate.
Postpartum Hemorrhage (The 4 Ts)
Defined as blood loss ≥ 1000 mL or bleeding associated with signs of hypovolemia within 24 hours of birth:
| Etiologic 'T' (Frequency) | Underlying Risk Factors & Presentation | Physical Exam & Uterine Palpation | Stepwise Medical & Surgical Management |
|---|---|---|---|
| Tone: Uterine Atony (70–80%) | Fetal macrosomia, multiple gestation, polyhydramnios, chorioamnionitis, prolonged/precipitous labor, magnesium sulfate, halogenated anesthetics | Boggy, soft, enlarged uterus palpable above the umbilicus | 1st: Bimanual uterine massage + High-dose Oxytocin IV/IM. 2nd: Methylergonovine (0.2 mg IM; CONTRAINDICATED in hypertension/preeclampsia!), Carboprost (PGF2-alpha IM; CONTRAINDICATED in asthma!), or Misoprostol (PGE1) + Tranexamic Acid (1 g IV within 3h). 3rd: Bakri balloon tamponade -> B-Lynch suture / uterine artery ligation -> Hysterectomy |
| Trauma: Lacerations, Hematoma, Inversion, Rupture (20%) | Operative vaginal delivery (forceps/vacuum), shoulder dystocia, excessive fundal/cord traction, prior classical cesarean scar | Firm, contracted midline uterus with ongoing bright red vaginal bleeding; or smooth mass protruding from cervix (uterine inversion) | Inspect cervix/vagina and repair lacerations; for Uterine Inversion: STOP uterotonics, relax uterus (nitroglycerin/terbutaline/halogenated anesthetic), perform manual Johnson reduction, THEN start oxytocin |
| Tissue: Retained Placenta / Accreta Spectrum (10%) | Incomplete placental cotyledon on inspection, succenturiate lobe, or placenta accreta/increta/percreta (prior C-section + placenta previa) | Missing placental fragment on bedside inspection or failure of placenta to separate within 30 minutes | Bedside ultrasound + manual extraction or ultrasound-guided suction curettage (sharp curettage risks Asherman intrauterine adhesions); placenta accreta spectrum requires planned cesarean hysterectomy |
| Thrombin: Coagulopathy (1%) | Placental abruption, amniotic fluid embolism (AFE), intrauterine fetal demise (IUFD), severe preeclampsia/HELLP, inherited vWD/hemophilia | Generalized oozing from venipuncture sites, incisions, and mucosa; low fibrinogen (<200 mg/dL defines severe PPH progression risk) | Massive transfusion protocol (1:1:1 pRBC:FFP:Platelets) + Cryoprecipitate to maintain serum fibrinogen >200-300 mg/dL + Tranexamic Acid |
1. Tone (Uterine Atony — 70% of Cases)
Soft, boggy, poorly contracted uterus above the umbilicus. Management: Bimanual uterine massage, high-dose IV Oxytocin, Methylergonovine (Methergine - contraindicated in hypertension), Carboprost (Hemabate - contraindicated in asthma), Misoprostol.
2. Trauma (Lacerations, Hematomas — 20%)
Firm contracted uterus with continuous trickling of bright red blood. Requires systematic speculum examination and surgical repair.
3. Tissue (Retained Placenta — 10%)
Missing cotyledons on placental inspection. Requires manual exploration or suction curettage.
4. Thrombin (Coagulopathy — 1%)
Failure of blood to clot. Associated with placental abruption, severe preeclampsia, amniotic fluid embolism.
Uterine Atony Pharmacology & Comorbidity Contraindications (Asthma, Hypertension, Renal/Hepatic)
Postpartum Hemorrhage (PPH)—defined by ACOG as cumulative blood loss ≥1,000 mL or blood loss accompanied by signs/symptoms of hypovolemia within 24 hours of delivery—is caused in 70% to 80% of cases by Uterine Atony ('Tone') (risk factors: chorioamnionitis, prolonged oxytocin exposure, magnesium sulfate, multiparity, macrosomia, twin gestation, polyhydramnios, or halothane anesthesia). Immediate management begins with bimanual uterine massage, bladder emptying, high-dose IV Oxytocin, and early IV Tranexamic Acid (TXA, 1 g IV over 10 minutes within 3 hours of birth). When second-line uterotonics are required, boards always test their absolute comorbidity contraindications: (1) Methylergonovine (Methergine, 0.2 mg IM) is an ergot alkaloid alpha-adrenergic/serotonergic vasoconstrictor that is STRICTLY CONTRAINDICATED in Hypertension, Preeclampsia, or Coronary Artery Disease (causes hypertensive crisis and stroke); (2) Carboprost tromethamine (Hemabate, PGF2α, 250 μg IM) stimulates bronchial smooth muscle contraction and is STRICTLY CONTRAINDICATED in Asthma (causes life-threatening bronchospasm; also causes severe watery diarrhea); (3) Misoprostol (PGE1, 600–1,000 μg PR/SL) is safe in both asthma and hypertension (causes benign prostaglandin fever/shivering).
Surgical Escalation for Refractory PPH (Bakri Balloon, B-Lynch, Uterine Artery Ligation) & Sheehan Syndrome
If bimanual massage and uterotonics fail to control hemorrhage, rapidly inspect the genital tract for Trauma (cervical/vaginal lacerations, paravaginal hematoma, or uterine inversion—presenting as a smooth round mass protruding through the cervix after excessive umbilical cord traction; treat by stopping uterotonics, relaxing the uterus with nitroglycerin/terbutaline, and manually replacing the fundus [Johnson maneuver] BEFORE restarting oxytocin) and ultrasound/explore the cavity for retained placental fragments ('Tissue' / placenta accreta spectrum) or Thrombin (DIC from amniotic fluid embolism, abruption, or IUFD). For refractory atony, escalate sequentially to intrauterine tamponade (Bakri balloon or Jada vacuum device) → uterine artery embolization (if hemodynamically stable) or laparotomy with B-Lynch uterine compression sutures and bilateral uterine/utero-ovarian artery ligation (O'Leary sutures) (note: internal iliac artery ligation fails if collateral flow persists) → peripartum hysterectomy. Survivable massive PPH with hypotension infarcts the physiologically hypertrophied anterior pituitary lactotrophs and gonadotrophs, causing Sheehan Syndrome—presenting initially with failure to lactate postpartum (prolactin deficiency) followed by secondary amenorrhea, loss of pubic/axillary hair, hypothyroidism, and adrenal insufficiency.
Third-Trimester Bleeding Differential: Previa, Abruption, Vasa Previa & Uterine Rupture
Antepartum hemorrhage after 20 weeks gestation complicates 4–5% of pregnancies and represents a time-critical obstetric emergency requiring immediate hemodynamic stabilization and systematic diagnostic differentiation. The cardinal clinical rule governing all third-trimester bleeding is that a digital cervical examination is strictly contraindicated until transabdominal followed by transvaginal ultrasonography definitively excludes placenta previa. Establishing two large-bore intravenous lines, obtaining a type and crossmatch, quantifying maternal Rh status for Rho(D) immune globulin calculation via the Kleihauer-Betke acid elution test, and initiating continuous cardiotocographic monitoring occur simultaneously. Differentiating maternal from fetal blood in vaginal effluent is rapidly accomplished via the Apt test (fetal hemoglobin HbF resists alkali denaturation by 1% KOH and remains pink, whereas adult HbA denatures to brown-yellow).
| Condition | Pathophysiology & Risk Factors | Bleeding & Abdominal Pain | Fetal Heart Rate & Exam Findings | Definitive Management Protocol |
|---|---|---|---|---|
| Placenta Previa | Blastocyst implantation over or near internal cervical os; prior C-section, multiparity, advanced maternal age, smoking, multiple gestation | Painless bright red vaginal bleeding; often sentinel bleed at 28–32 weeks | Soft, non-tender, relaxed uterus; normal FHR initially (until maternal shock); NO digital exam! | Transvaginal US confirms diagnosis; pelvic rest; corticosteroids if < 34w; scheduled C-section at 36–37 weeks (or emergent C-section if refractory hemorrhage) |
| Abruptio Placentae | Premature separation of normally implanted placenta from decidua basalis via retroplacental maternal arterial rupture; HTN/preeclampsia (#1), cocaine, trauma, smoking, prior abruption | Painful dark red vaginal bleeding (20% concealed hemorrhage behind placenta with no visible blood) | Hypertonic, rigid, 'woody' board-like tender uterus; high-frequency contractions; fetal bradycardia or late decelerations; high risk of DIC | Clinical diagnosis (US sensitivity only 25–50%); aggressive blood/FFP/cryoprecipitate resuscitation; emergent C-section if fetal distress or unstable mother; vaginal delivery if stable/IUFD |
| Vasa Previa | Fetal umbilical vessels traverse the fetal membranes over the internal cervical os unprotected by Wharton jelly; velamentous cord insertion, bilobed/succenturiate placenta, IVF | Painless vaginal bleeding immediately upon amniotomy (ROM); rapid fetal exsanguination (fetal blood volume is only ~80–100 mL/kg) | Triad: Rupture of membranes + painless bleeding + acute fetal bradycardia or sinusoidal FHR tracing | Antenatal diagnosis via TVUS with color Doppler; immediate emergent C-section upon rupture (fetal mortality > 60% if delayed); planned C-section at 34–37w |
| Uterine Rupture | Full-thickness disruption of uterine myometrium and serosa; TOLAC/VBAC with prior classical vertical C-section scar, myomectomy, oxytocin hyperstimulation, grand multiparity | Sudden tearing abdominal pain (± vaginal bleeding, often intra-abdominal hemoperitoneum) with abrupt cessation of contractions | Fetal bradycardia (#1 earliest sign), loss of fetal station on palpation, palpable fetal parts in abdomen | Immediate laparotomy and cesarean delivery with uterine repair or emergency hysterectomy |
| Placenta Accreta Spectrum | Defective decidualization (absent Nitabuch layer) allowing trophoblastic invasion into myometrium (Accreta: attaches; Increta: invades myometrium; Percreta: perforates serosa/bladder) | Profuse life-threatening hemorrhage during attempted manual placental extraction after delivery | Antenatal US shows placenta previa over prior uterine scar with placental lacunae ('Swiss-cheese') and loss of retroplacental clear zone | Planned cesarean hysterectomy at 34–35 weeks leaving placenta in situ (never attempt manual extraction) |
Kleihauer-Betke Test & Rh Alloimmunization Prophylaxis
Every RhD-negative mother with an RhD-positive (or unknown) fetus experiencing antepartum hemorrhage, abdominal trauma, placental abruption, or external cephalic version requires anti-D immune globulin (RhoGAM). The standard 300 μg intramuscular dose given at 28 weeks and within 72 hours postpartum neutralizes up to 30 mL of fetal whole blood (15 mL of fetal RBCs). In massive fetomaternal hemorrhage (such as abruption), the Kleihauer-Betke test exposes maternal blood smear to acid, eluting adult HbA while leaving fetal HbF intact within brightly stained pink cells, allowing calculation of exact additional RhoGAM vials needed.
Disseminated Intravascular Coagulation (DIC) in Abruption
Placental abruption is the most common obstetric cause of consumptive coagulopathy (DIC). Extravasation of decidual tissue factor (thromboplastin) into the maternal venous circulation triggers widespread thrombin generation, platelet consumption, and secondary fibrinolysis. Laboratory findings include markedly decreased fibrinogen (< 200 mg/dL; normal in pregnancy is 400–650 mg/dL), prolonged PT/PTT, thrombocytopenia, elevated D-dimer, and microangiopathic schistocytes. Resuscitation requires massive transfusion protocols prioritizing cryoprecipitate (to maintain fibrinogen > 150–200 mg/dL), fresh frozen plasma, and packed red cells alongside prompt uterine evacuation.
Trial of Labor After Cesarean (TOLAC) Eligibility vs. Contraindications
While patients with one or two prior low-transverse Pfannenstiel uterine incisions are candidates for a Trial of Labor After Cesarean (TOLAC) with a uterine rupture risk < 1%, absolute contraindications to TOLAC include a prior classical (vertical) cesarean incision (rupture risk 4–9%), prior T-incision, prior transfundal myomectomy entering the endometrial cavity, or prior uterine rupture. Patients with these high-risk scars must undergo scheduled repeat cesarean delivery at 36–37 weeks prior to the onset of spontaneous labor.
Preeclampsia with Severe Features, HELLP Syndrome & Magnesium Toxicity Ladder
Preeclampsia originates from abnormal cytotrophoblastic invasion of the maternal uterine spiral arteries during early placentation. Failure of spiral arteries to remodel from high-resistance, low-capacitance muscular vessels into low-resistance, high-capacitance channels leads to placental ischemia and systemic release of anti-angiogenic factors (soluble fms-like tyrosine kinase-1 [sFlt-1] and soluble endoglin), which antagonize VEGF and placental growth factor (PlGF). The resulting widespread maternal endothelial dysfunction produces systemic vasospasm, capillary leak, glomerular endotheliosis (proteinuria), periportal hepatic necrosis, and cerebral edema. Definitive cure requires delivery of the placenta, balanced against fetal gestational maturity.
| Serum Magnesium Level | Clinical & Neurologic Manifestations | Immediate Management Intervention |
|---|---|---|
| 1.5 – 2.5 mEq/L (1.8 – 3.0 mg/dL) | Normal baseline physiologic serum concentration | Initiate standard loading dose (4–6 g IV over 20 min) followed by maintenance (1–2 g/hr) |
| 4.0 – 7.0 mEq/L (4.8 – 8.4 mg/dL) | Therapeutic anticonvulsant range for eclampsia prophylaxis; mild flushing, warmth, diaphoresis | Continue maintenance infusion; monitor urine output (≥ 30 mL/hr), respiratory rate, and patellar reflexes hourly |
| 7.0 – 10.0 mEq/L (8.5 – 12.0 mg/dL) | Loss of patellar deep tendon reflexes (areflexia) — earliest clinical sign of toxicity; somnolence, slurred speech, diplopia | Stop Magnesium Sulfate infusion immediately; check stat serum Mg2+ level; restart at lower rate once reflexes return |
| 10.0 – 13.0 mEq/L (12.0 – 16.0 mg/dL) | Respiratory paralysis / depression (< 12 breaths/min), hypoxia, PR/QRS/QT prolongation, heart block | Stop MgSO4; administer IV Calcium Gluconate 1 g (10 mL of 10% solution) over 3–5 min; provide bag-valve-mask or endotracheal ventilation |
| > 15.0 – 20.0 mEq/L (> 18.0 mg/dL) | Complete sinoatrial/AV block and asystolic cardiac arrest | ACLS resuscitation, immediate IV Calcium Gluconate/Chloride, IV loop diuretics or emergent hemodialysis if renal failure present |
Antihypertensive Pharmacotherapy in Acute Severe Hypertension
Persistent systolic BP ≥ 160 mmHg or diastolic BP ≥ 110 mmHg lasting ≥ 15 minutes constitutes a hypertensive obstetric emergency due to the risk of maternal hemorrhagic stroke and placental abruption. First-line acute agents include IV Labetalol (20 mg IV bolus, escalating to 40 mg and 80 mg every 10 min; avoid in asthma, overt heart failure, or bradycardia), IV Hydralazine (5–10 mg IV every 20 min), or immediate-release oral Nifedipine (10–20 mg PO every 20 min). Target blood pressure is 140–150 / 90–100 mmHg to prevent precipitous drops in uteroplacental perfusion.
Gestational Age Delivery Timing & Low-Dose Aspirin Prophylaxis
Delivery timing is strictly dictated by disease severity: Gestational hypertension or Preeclampsia WITHOUT severe features is managed expectantly until 37 0/7 weeks gestation. Preeclampsia WITH severe features requires delivery at 34 0/7 weeks gestation (with antenatal betamethasone administered if < 34 weeks, unless maternal/fetal instability mandates immediate delivery). Immediate delivery regardless of gestational age is required for Eclampsia, HELLP syndrome, pulmonary edema, DIC, placental abruption, or refractory severe hypertension. For future pregnancies, patients with high-risk factors (prior preeclampsia, multifetal gestation, chronic HTN, diabetes, renal disease, SLE) should initiate low-dose Aspirin (81 mg daily) at 12–16 weeks gestation.
HELLP Syndrome & Subcapsular Hepatic Hematoma
HELLP syndrome (Hemolysis with microangiopathic schistocytes and LDH > 600 IU/L, Elevated Liver enzymes AST/ALT ≥ 2× ULN, and Low Platelets < 100,000/μL) complicates 10–20% of severe preeclampsia cases. Fibrin deposition in hepatic sinusoids causes periportal necrosis and Glisson capsule distension, presenting as severe right upper quadrant or epigastric pain, nausea, and vomiting. Sudden hypotension and shoulder pain indicate rupture of a subcapsular hepatic hematoma, requiring massive transfusion and emergent surgical packing or hepatic artery embolization. Management of HELLP requires IV magnesium sulfate, blood pressure control, and prompt delivery.
Intrapartum Fetal Heart Rate Monitoring (VEAL CHOP) & Category I–III Resuscitation
Electronic fetal monitoring (cardiotocography) evaluates fetal oxygenation and acid-base balance during labor by correlating fetal heart rate (FHR) patterns with uterine contractions. A normal baseline FHR ranges from 110 to 160 beats/min (fetal tachycardia > 160 bpm is most commonly caused by intra-amniotic infection / chorioamnionitis, maternal fever, or beta-agonist drugs; fetal bradycardia < 110 bpm for ≥ 10 min indicates severe hypoxia, cord prolapse, uterine rupture, or maternal hypotension). Baseline moderate variability (amplitude fluctuations of 6–25 bpm) is the single most reliable indicator of an intact fetal CNS and normal fetal acid-base status (absence of acidemia). The VEAL CHOP mnemonic pairs deceleration morphologies directly with their underlying mechanical or hypoxic etiology.
| FHR Pattern (VEAL) | Etiology (CHOP) | Waveform Timing & Morphology | Targeted Physiological Intervention |
|---|---|---|---|
| V — Variable Decelerations | C — Cord Compression (oligohydramnios, nuchal/prolapsed cord) | Abrupt drop (< 30 sec from onset to nadir) of ≥ 15 bpm lasting 15 sec to 2 min; variable timing relative to contractions | Maternal repositioning (left/right lateral), inspect for cord prolapse; transcervical amnioinfusion if recurrent variables persist |
| E — Early Decelerations | H — Head Compression (fetal vagal nerve reflex during descent) | Gradual symmetric drop (≥ 30 sec to nadir) where nadir mirrors the peak of the uterine contraction | Benign physiologic finding; continue routine labor observation without intervention |
| A — Accelerations | O — Okay / Oxygenated (intact sympathetic response) | Abrupt increase ≥ 15 bpm above baseline lasting ≥ 15 sec (≥ 10 bpm for ≥ 10 sec if < 32 weeks) | Reassuring; reliably excludes fetal metabolic acidemia (fetal pH > 7.20) |
| L — Late Decelerations | P — Placental Insufficiency (abruption, preeclampsia, epidural hypotension, uterine tachysystole) | Gradual delayed drop where onset, nadir, and recovery occur AFTER the beginning, peak, and end of the contraction | Intrauterine resuscitation: Left lateral decubitus, discontinue oxytocin, IV crystalloid bolus, high-flow O2, phenylephrine/ephedrine if hypotensive |
| Sinusoidal Pattern | Severe Fetal Anemia / Hypoxia (vasa previa bleed, Rh hydrops, parvovirus B19, fetomaternal hemorrhage) | Smooth, undulating sine-wave baseline with frequency of 3–5 cycles/min persisting ≥ 20 minutes with absent variability | Category III emergency: immediate emergent cesarean delivery or intrauterine transfusion |
NICHD Three-Tiered FHR Category System (Categories I, II, and III)
Category I (Normal): Baseline 110–160 bpm, moderate variability (6–25 bpm), no late or variable decelerations, early decelerations/accelerations may be present or absent; manage with routine monitoring. Category II (Indeterminate): Tracings not meeting Category I or III (e.g., minimal variability without recurrent decelerations, or recurrent variables with moderate variability); requires targeted intrauterine resuscitation and close reassessment. Category III (Abnormal / Acidemic): Absent variability accompanied by recurrent late decelerations, recurrent variable decelerations, or bradycardia, OR a sinusoidal pattern. Category III tracings signify imminent fetal asphyxia and mandate immediate intrauterine resuscitation while preparing for emergent operative vaginal or cesarean delivery.
Step-by-Step Intrauterine Resuscitation Protocol
Whenever recurrent late decelerations, prolonged decelerations, or Category II/III tracings arise, execute the five-step intrauterine resuscitation bundle immediately: (1) Reposition the mother into the left lateral decubitus position to relieve inferior vena cava and abdominal aortic compression by the gravid uterus, maximizing venous return and cardiac output; (2) Discontinue all uterotonics (Oxytocin / Pitocin) and administer a tocolytic (Terbutaline 0.25 mg SC) if uterine tachysystole (> 5 contractions in 10 minutes) is present; (3) Administer an IV lactated Ringer bolus (500–1000 mL); (4) Apply maternal supplemental oxygen via non-rebreather mask; and (5) Perform a vaginal examination to rule out umbilical cord prolapse or rapid cervical descent.
Fetal Scalp Stimulation & Amnioinfusion Indications
When a Category II tracing exhibits minimal or absent baseline variability without spontaneous accelerations, performing digital fetal scalp stimulation (or vibroacoustic stimulation) during a vaginal exam tests fetal acid-base reserve: an induced acceleration of ≥ 15 bpm lasting ≥ 15 seconds confirms a fetal pH > 7.20 and rules out acidosis. Conversely, if a patient with ruptured membranes exhibits recurrent variable decelerations refractory to maternal repositioning, infusing sterile normal saline into the intrauterine cavity via an intrauterine pressure catheter (amnioinfusion) cushions the umbilical cord and resolves cord compression.
Shoulder Dystocia (HELPERR), Umbilical Cord Prolapse & Amniotic Fluid Embolism
Intrapartum mechanical and cardiopulmonary catastrophes require reflexive, split-second execution of standardized obstetric maneuvers. Shoulder dystocia occurs when the fetal anterior shoulder impacts behind the maternal pubic symphysis (or less commonly, the posterior shoulder impacts on the sacral promontory) following delivery of the fetal head, halting spontaneous restitution and causing the fetal head to retract tightly against the maternal perineum ('Turtle sign'). Because umbilical cord compression within the birth canal decreases fetal arterial pH by ~0.04 per minute, delivery must be accomplished within 5 minutes to prevent hypoxic-ischemic encephalopathy. Major risk factors include fetal macrosomia (> 4,500 g in non-diabetics, > 4,000 g in diabetics), maternal diabetes mellitus (which increases fetal shoulder-to-head biacromial circumference), maternal obesity, and prior shoulder dystocia.
| Maneuver / Emergency | Execution Technique & Biomechanical Mechanism | Key Complications & Clinical Pearls |
|---|---|---|
| 1. McRoberts Maneuver + Suprapubic Pressure | First-line intervention: Hyperflex maternal thighs tightly against abdomen (flattens lumbosacral promontory and rotates pubic symphysis cephalad) while assistant applies downward/lateral suprapubic pressure | Resolves > 50–60% of shoulder dystocias; NEVER apply fundal pressure (causes uterine rupture and brachial plexus avulsion) |
| 2. Rubin & Woods Corkscrew Maneuvers | Internal rotational maneuvers: apply pressure to the posterior aspect of the anterior/posterior fetal shoulder (Rubin adducts shoulders) to rotate fetus 180° like a screw thread | Decreases bisacromial diameter and rotates impacted anterior shoulder into the wider oblique pelvic diameter |
| 3. Delivery of the Posterior Arm | Insert hand along sacral hollow, splint fetal posterior humerus, flex fetal elbow across the chest, and sweep posterior forearm and hand out of the vagina | Replaces biacromial diameter with narrower axilloacromial diameter; risk of clavicular or humeral fracture (heals rapidly without permanent sequelae) |
| 4. Gaskin All-Fours & Zavanelli Maneuver | Gaskin: roll mother onto hands and knees. Zavanelli (last resort): administer terbutaline tocolysis, rotate fetal head back to OA, flex and push head back into vagina for emergent C-section | Other rescue options: intentional fetal clavicular fracture (pulling anterior clavicle outward away from lung) or maternal symphysiotomy |
| Umbilical Cord Prolapse | Cord descends past presenting part after ROM → cold/vasospasm & compression → abrupt severe fetal bradycardia with palpable pulsatile vaginal mass | Elevate fetal presenting part manually off the cord (keep hand in vagina until C-section!), knee-chest/Trendelenburg position, emergent C-section |
| Amniotic Fluid Embolism (AFE) | Amniotic fluid/fetal squamous cells enter maternal venous sinuses → anaphylactoid pulmonary vasoconstriction → classic triad: sudden hypoxia, hypotension/cardiogenic shock, and consumptive DIC | Supportive ICU resuscitation: immediate intubation, vasopressors, massive transfusion protocol (1:1:1 PRBC:FFP:platelets + cryoprecipitate), emergent perimortem C-section |
Neonatal Brachial Plexus Injuries: Erb-Duchenne vs. Klumpke Palsy
Excessive lateral traction on the fetal head during shoulder dystocia stretches the cervical nerve roots. Erb-Duchenne palsy (C5–C6 injury) is the most common obstetric brachial plexus injury, paralyzing the deltoid, supraspinatus, infraspinatus, and biceps brachii. The affected arm hangs in the classic 'waiter's tip' posture (adducted, internally rotated shoulder, extended elbow, pronated forearm, flexed wrist) with an absent Moro reflex on the ipsilateral side but an intact palmar grasp reflex. Conversely, Klumpke palsy (C8–T1 injury) damages the intrinsic hand muscles ('total claw hand') with an absent grasp reflex and possible ipsilateral Horner syndrome (ptosis, miosis, anhidrosis) from T1 sympathetic rootlet avulsion.
Elective Cesarean Thresholds to Prevent Shoulder Dystocia
While routine induction of labor for suspected fetal macrosomia does not reduce maternal morbidity, prophylactic scheduled cesarean delivery is indicated to prevent catastrophic shoulder dystocia when estimated fetal weight exceeds 5,000 g in women WITHOUT diabetes or 4,500 g in women WITH gestational or pregestational diabetes mellitus. Additionally, patients with a history of severe prior shoulder dystocia complicated by neonatal brachial plexus injury or hypoxic encephalopathy are offered scheduled cesarean delivery.
Uterine Inversion Recognition & Immediate Replacement
Acute uterine inversion occurs when excessive umbilical cord traction is applied during the third stage of labor prior to complete placental separation (especially with a fundally implanted placenta or placenta accreta). It presents with sudden, severe lower abdominal pain, profuse postpartum hemorrhage, a smooth round beefy-red mass protruding into the vagina or introitus, and absence of the uterine fundus on abdominal palpation. Management requires immediate manual replacement (Johnson maneuver) by pushing the inverted fundus cephalad through the cervical ring BEFORE removing the attached placenta, using uterine relaxants (nitroglycerin, terbutaline, or halogenated anesthetics) if a constriction ring forms, followed by uterotonics (oxytocin) once anatomical position is restored.
COMLEX / OMM Integration
NBOME High-Yield Correlate
Obstetric Viscerosomatics, Sacral Biomechanics & Peripartum OMT
- Autonomic Innervation of the Uterus & Cervix: Sympathetic preganglionic fibers originate from T10–L2, traverse the inferior mesenteric and hypogastric plexuses, and mediate uterine smooth muscle contraction and vasoconstriction. Parasympathetic fibers originate from the pelvic splanchnic nerves (S2–S4) and promote cervical ripening, vasodilation, and relaxation of the lower uterine segment. During early labor, excessive sympathetic tone from pain and anxiety at T10–L2 can produce uncoordinated hypertonic uterine contractions (hypertonic uterine dysfunction).
- Chapman Reflexes & Counterstrain: Anterior Chapman points for the uterus lie at the superior border of the pubic symphysis and along the medial aspect of the obturator foramen; broad ligament points reside along the lateral margin of the iliotibial tract from the greater trochanter to the knee. Posterior Chapman points for the uterus/prostate lie between the PSIS and the spinous process of L5. Lumbar and sacral counterstrain tenderpoints (particularly PL3–PL5 and mid-pole sacral points) help alleviate gravid lumbosacral strain.
- Pelvic Biomechanics & Safe OMT Modalities: As the fetus engages the pelvic inlet, the sacral base moves posteriorly (counternutation) to widen the inlet; during delivery through the pelvic outlet, the sacral base moves anteriorly (nutation) to widen the anteroposterior outlet diameter. Gentle sacral rocking, myofascial release of the pelvic diaphragm, and paraspinal inhibition at T10–L2 are safe in pregnancy. Contraindications: Compression of the fourth ventricle (CV4) is contraindicated in preterm patients (< 37 weeks) because it stimulates oxytocin release and uterine contractions. High-velocity low-amplitude (HVLA) thrusts to the lumbar spine and pelvis are avoided in the third trimester due to relaxin-mediated ligamentous laxity, and all OMT is deferred during acute placenta previa, abruption, or eclampsia.
Board Traps & Common Distractors
- Trap: Performing a sterile digital vaginal examination in a pregnant patient presenting with third-trimester vaginal bleeding before ultrasound confirms placental location. If placenta previa is present, a digital exam can perforate the placenta and cause catastrophic, fatal maternal-fetal exsanguination!
- Trap: Administering Methylergonovine (Methergine) for postpartum uterine atony in a patient with preeclampsia, chronic hypertension, or gestational hypertension. Methylergonovine is an ergot alkaloid that causes severe alpha-adrenergic vasoconstriction, precipitating hypertensive emergency, stroke, or coronary vasospasm.
- Trap: Administering Carboprost (Hemabate / prostaglandin F2α) for postpartum hemorrhage in a patient with asthma. Prostaglandin F2α causes profound smooth muscle bronchoconstriction and life-threatening status asthmaticus.
- Trap: Applying fundal pressure during a shoulder dystocia emergency. Fundal pressure impacts the anterior fetal shoulder further behind the maternal pubic symphysis, drastically increasing the risk of uterine rupture, C5–C6 brachial plexus avulsion (Erb-Duchenne palsy), and fetal hypoxia.
- Trap: Missing early magnesium sulfate toxicity in a preeclamptic patient with oliguria. Because magnesium is excreted exclusively by the kidneys, preeclamptic renal insufficiency rapidly elevates serum levels. Loss of patellar deep tendon reflexes (> 7 mEq/L) precedes respiratory depression (> 10 mEq/L) and cardiac arrest; immediately stop the infusion and give IV Calcium Gluconate.
- Trap: Giving ACE inhibitors, ARBs, or nitroprusside for acute severe hypertension in pregnancy. ACEi/ARBs cause fetal renal dysgenesis, oligohydramnios, and calvarial hypoplasia; first-line acute agents are IV Labetalol, IV Hydralazine, or immediate-release oral Nifedipine.
- Trap: Delaying emergent cesarean delivery to perform fetal scalp testing when a Category III fetal heart rate tracing (absent variability with recurrent late/variable decelerations, bradycardia, or sinusoidal pattern) persists despite intrauterine resuscitation.
Previous Chapter
•
Vol 2: Clinical Ch. 9
Sepsis, Septic Shock & Hemodynamic Profiles
Vol 2: Clinical Ch. 11
•
Next Chapter
Thyroid Storm, Myxedema Coma & Adrenal Crisis
Table of Contents (105 Chapters)
Volume 2: Organ System Clinical Pathology • Chapter 10 of 60